Cargando…
Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008–2014
Background. Echinocandins are first-line treatment for Candida glabrata candidemia. Echinocandin resistance is concerning due to limited remaining treatment options. We used data from a multisite, population-based surveillance program to describe the epidemiology and risk factors for echinocandin no...
Autores principales: | Vallabhaneni, Snigdha, Cleveland, Angela A., Farley, Monica M., Harrison, Lee H., Schaffner, William, Beldavs, Zintar G., Derado, Gordana, Pham, Cau D., Lockhart, Shawn R., Smith, Rachel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677623/ https://www.ncbi.nlm.nih.gov/pubmed/26677456 http://dx.doi.org/10.1093/ofid/ofv163 |
Ejemplares similares
-
Prevalence of and Factors Associated with Clostridium difficile Co-infection Among Patients with Candidemia, United States, 2014–2016
por: Tsay, Sharon, et al.
Publicado: (2017) -
Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016) -
Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015) -
146 Review of Empiric Echinocandin Therapy for Candidemia
por: Amado, Cristina, et al.
Publicado: (2014) -
372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018)